You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

camrelizumab；rivoceranib

Showing 1 - 1 of 1
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Hepatocellular Carcinoma (HCC) Trial in Beijing (camrelizumab;Rivoceranib, Rivoceranib, Sorafenib)

Enrolling by invitation
  • Advanced Hepatocellular Carcinoma (HCC)
  • camrelizumab；Rivoceranib
  • +3 more
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Oct 21, 2021